Vimarsana
Biggest News Aggregation in the World

Page 5 - Johnp Moore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnp Moore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnp Moore Today - Breaking & Trending Today

Why a 'tripledemic' is keeping many of us sick for weeks at a time - Vimarsana News

Why a 'tripledemic' is keeping many of us sick for weeks at a time

It’s like 'a big bomb of viruses went off,' said pediatrician treating kids with flu, RSV, strep and COVID.

Hiltzik: Elon Musk goes down the right-wing rabbit hole - Vimarsana News

Hiltzik: Elon Musk goes down the right-wing rabbit hole

Elon Musk is magnifying hate speech and extremist tropes on Twitter, making the platform the 'free-for-all hellscape' he promised to avoid.

Hiltzik: Is Elon Musk a genius or an idiot? - Los Angeles Times - Vimarsana News

Hiltzik: Is Elon Musk a genius or an idiot? - Los Angeles Times

Elon Musk has mistaken his Tesla and SpaceX companies' success as testaments to his brilliance. Is that why is he taking such dumb steps with Twitter?

Pfizer says new booster shot increases omicron-fighting antibodies - Vimarsana News

Pfizer says new booster shot increases omicron-fighting antibodies

Pfizer announced Friday that its updated coronavirus booster shot targeting the omicron variant succeeded in strengthening the body’s army of disease-fighting antibodies, even as questions persist about the vaccine’s continued effectiveness against a swarm of later-generation versions of omicron. The findings reinforce the public health message that the new bivalent boosters, which were rebooted in […]

FDA authorizes updated COVID-19 boosters from Moderna, Pfizer in hopes of preventing a fall omicron surge - Vimarsana News

FDA authorizes updated COVID-19 boosters from Moderna, Pfizer in hopes of preventing a fall omicron surge

COVID-19 booster shots that target the BA.4 and BA.5 omicron subvariants could be available next week after the U.S. Food and Drug Administration authorized updated vaccines from Moderna and Pfizer. Federal health officials hope the boosters will help prevent a fall surge of infections, but some scientists fear the decision was rushed, saying the FDA should have waited to gain data from human clinical trials before making its decision.